Pharmaceutical formulation of arsenic trioxide
US11583552B2 · kind B2 · utility
0Cited by
10References
14Claims
0Family size
Inventor
Key dates
| Filing date | Aug 24, 2021 |
| Grant date | Feb 21, 2023 |
| Priority date | — |
| Expiry date | Aug 24, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/4866
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Liquid fill matrices comprising dissolved arsenic trioxide and having not more than 20% aqueous component and at least 80% nonaqueous component, wherein the components are miscible, are described as well as processes of preparing such liquid fill matrices and processing the liquid fill matrices into dosage forms including soft capsules; for the treatment of various ailments, such as cancer and GVHD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.